Datta M W, Macri E, Signoretti S, Renshaw A A, Loda M
Department of Pathology, Froedtert Memorial Lutheran Hospital, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Mod Pathol. 2001 May;14(5):437-42. doi: 10.1038/modpathol.3880331.
The tumor suppressor gene p53 has been shown to transcriptionally regulate expression of the cell cycle dependent kinase inhibitor p21. p53 is in turn regulated by the ubiquitin ligase mouse double minute-2 (mdm-2). We have set out to examine p21 expression in testicular germ cell tumors and its relationship with p53 and mdm-2 expression.
Immunohistochemical analysis was performed on formalin-fixed paraffin-embedded tissue for p53, p21, and mdm-2 in 31 testicular germ cell tumors, which included 17 pure seminomas and 14 mixed germ cell tumors composed predominantly of embryonal carcinoma. Twenty-seven cases contained adjacent areas of intratubular germ cell neoplasia (ITGCN).
17 out of 17 seminomas and 14 out of 14 embryonal carcinomas expressed p53 in both ITGCN and the invasive tumor. In contrast, none of the 17 seminomas and only 2 of 14 embryonal carcinomas revealed positive staining for p21 protein. p21 expression was noted in 18 of 27 cases (67%) of ITGCN, and in 16 of these cases (89%) the corresponding invasive tumor had lost p21 expression. In nine additional cases p21 expression was absent in both the invasive and intratubular tumor. mdm-2 expression was present in 8 out of 17 (47%) seminomas and 13 out of 14 (93%) embryonal carcinomas but was present in only 2 out of 27 (7%) cases of ITGCN. Statistically significant associations for loss of p21 and gain of mdm-2 expression in invasive tumors were present (P < .0001).
The co-expression of p53 and p21 in ITGCN is consistent with preservation of p53-directed induction of p21. The loss of p21 expression in invasive tumors suggests a disruption of the p53 regulatory pathway. The inverse correlation of p21 and mdm-2 expression in both ITGCN and invasive tumors could indicate that loss of the functional p53 regulatory pathway may be correlated with the onset of mdm-2 expression. These results raise the possibility that the loss of p21 expression may be associated with the development of invasive germ cell tumors from ITGCN. Persistent p53 expression in the presence of mdm-2 suggests that in testicular germ cell tumors, while mdm-2 can block the transactivation potential of p53, it can no longer target p53 for degradation.
肿瘤抑制基因p53已被证明可转录调节细胞周期依赖性激酶抑制剂p21的表达。而p53又受泛素连接酶小鼠双微体2(mdm - 2)的调节。我们着手研究睾丸生殖细胞肿瘤中p21的表达及其与p53和mdm - 2表达的关系。
对31例睾丸生殖细胞肿瘤的福尔马林固定石蜡包埋组织进行p53、p21和mdm - 2的免疫组织化学分析,其中包括17例纯精原细胞瘤和14例主要由胚胎癌组成的混合性生殖细胞肿瘤。27例包含管内生殖细胞肿瘤(ITGCN)的相邻区域。
17例精原细胞瘤中的17例以及14例胚胎癌中的14例在ITGCN和浸润性肿瘤中均表达p53。相比之下,17例精原细胞瘤中无一例显示p21蛋白阳性染色,14例胚胎癌中仅有2例显示阳性染色。在27例ITGCN病例中有18例(67%)检测到p21表达,其中16例(89%)相应的浸润性肿瘤失去了p21表达。另外9例病例的浸润性肿瘤和管内肿瘤均未检测到p21表达。17例精原细胞瘤中有8例(47%)、14例胚胎癌中有13例(93%)表达mdm - 2,但27例ITGCN病例中仅有2例(7%)表达mdm - 2。浸润性肿瘤中p21缺失与mdm - 2表达增加之间存在统计学上的显著关联(P <.0001)。
ITGCN中p53和p21的共表达与p53介导的p21诱导的保留一致。浸润性肿瘤中p21表达的缺失表明p53调节途径的破坏。ITGCN和浸润性肿瘤中p21与mdm - 2表达的负相关可能表明功能性p53调节途径的丧失可能与mdm - 2表达的开始相关。这些结果增加了p21表达缺失可能与ITGCN发展为浸润性生殖细胞肿瘤相关的可能性。在存在mdm - 2的情况下p53持续表达表明,在睾丸生殖细胞肿瘤中,虽然mdm - 2可以阻断p53的反式激活潜能,但它不再能将p53靶向降解。